Showing results (501-510 of 543) with videos related to

Sort By:
Pageof 55
Scientific Reports|March 29, 2017
Characterisation of male breast cancer: a descriptive biomarker study from a large patient seriesMatthew P Humphries, Sreekumar Sundara Rajan, Hedieh Honarpisheh, et al.
Journal of Clinical Immunology|September 29, 2021
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHDDanielle E Arnold, Rofida Nofal, Connor Wakefield, et al.
Blood Advances|April 18, 2025
The OHI index predicts early mortality from organ dysfunction and survival benefit from etoposide in lymphoma patientsAdi Zoref-Lorenz, Jun Murakami, Ronit Gurion, et al.
JAMA|May 13, 2010
Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemiaElliott P Vichinsky, Lynne D Neumayr, Jeffrey I Gold, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2017
Manipulating DNA damage-response signaling for the treatment of immune-mediated diseasesJonathan P McNally, Scott H Millen, Vandana Chaturvedi, et al.
ACS Chemical Biology|July 20, 2016
Facile Modulation of Antibody Fucosylation with Small Molecule Fucostatin Inhibitors and Cocrystal Structure with GDP-Mannose 4,6-DehydrataseJohn G Allen, Mirna Mujacic, Michael J Frohn, et al.
Blood Advances|December 3, 2025
Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: The REAL-HLH studyAdi Zoref-Lorenz, Carl E Allen, Edward M Behrens, et al.
JAMA Network Open|December 15, 2023
Guiding Principles to Address the Impact of Algorithm Bias on Racial and Ethnic Disparities in Health and Health CareMarshall H Chin, Nasim Afsar-Manesh, Arlene S Bierman, et al.
Blood|November 8, 2012
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomesRebecca A Marsh, Kanchan Rao, Prakash Satwani, et al.
Blood Advances|March 1, 2024
Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumabShanmuganathan Chandrakasan, Michael B Jordan, Ashley Baker, et al.
Pageof 55